Silu Cui, Qi Jiang, Hao Zhang, Zhang Wen, Panpan Luan, Yuxiao Hu et al. IMPI refines prognostic stratification among non-high NCCN-IPI risk DLBCL patients treated with R-CHOP: a real-world cohort study. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-16926-y. – URL: https://doi.org/10.1186/s12885-026-16926-y
Silu Cui, Qi Jiang, Hao Zhang, Zhang Wen, Panpan Luan, Yuxiao Hu, & Shuwei Guo (2026). IMPI refines prognostic stratification among non-high NCCN-IPI risk DLBCL patients treated with R-CHOP: a real-world cohort study. BMC Cancer. https://doi.org/10.1186/s12885-026-16926-y
Silu Cui, et al. “IMPI refines prognostic stratification among non-high NCCN-IPI risk DLBCL patients treated with R-CHOP: a real-world cohort study.” BMC Cancer, 2026. doi:10.1186/s12885-026-16926-y.
@article{Cui2026,
title = {IMPI refines prognostic stratification among non-high NCCN-IPI risk DLBCL patients treated with R-CHOP: a real-world cohort study},
author = {Cui, Silu and Jiang, Qi and Zhang, Hao and Wen, Zhang and Luan, Panpan and Hu, Yuxiao and Guo, Shuwei},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-16926-y},
url = {https://doi.org/10.1186/s12885-026-16926-y}
}